Related references
Note: Only part of the references are listed.Optimized two-step electroporation process to achieve efficient nonviral-mediated gene insertion into primary T cells
Ming Yang et al.
FEBS OPEN BIO (2022)
Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells
Khaled Sanber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
Reuben Benjamin et al.
LANCET (2020)
Use of a new RNA next generation sequencing approach for the specific detection of virus infection in cells
Audrey Brussel et al.
BIOLOGICALS (2019)
Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion
Toshinobu Nishimura et al.
EXPERIMENTAL HEMATOLOGY (2019)
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
J. Bercu et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2019)
From fiction to science: clinical potentials and regulatory considerations of gene editing
Maria Schacker et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Viral Vectors: The Road to Reducing Genotoxicity
Rhiannon M. David et al.
TOXICOLOGICAL SCIENCES (2017)
Allogeneic cell therapy manufacturing: process development technologies and facility design options
Saeed Abbasalizadeh et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Effective strategies for host cell protein clearance in downstream processing of monoclonal antibodies and Fc-fusion proteins
Yifeng Li
PROTEIN EXPRESSION AND PURIFICATION (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The blood DNA virome in 8,000 humans
Ahmed Moustafa et al.
PLOS PATHOGENS (2017)
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Establishing a control system using QbD principles
J. Felix Kepert et al.
BIOLOGICALS (2016)
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy
Ulrike Mock et al.
CYTOTHERAPY (2016)
Quality cell therapy manufacturing by design
Yonatan Y. Lipsitz et al.
NATURE BIOTECHNOLOGY (2016)
Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases
Shengdar Q. Tsai et al.
NATURE REVIEWS GENETICS (2016)
Development of robust antibody purification by optimizing protein-A chromatography in combination with precipitation methodologies
Srinivas Chollangi et al.
BIOTECHNOLOGY AND BIOENGINEERING (2015)
Multiplex Genome-Edited T-cell Manufacturing Platform for Off-the-Shelf Adoptive T-cell Immunotherapies
Laurent Poirot et al.
CANCER RESEARCH (2015)
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
Dachun Wang et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells
Cécile Mannioui et al.
Journal for ImmunoTherapy of Cancer (2013)
The need for innovation in biomanufacturing
Uwe Gottschalk et al.
NATURE BIOTECHNOLOGY (2012)
Albumin and mammalian cell culture: implications for biotechnology applications
Geoffrey L. Francis
CYTOTECHNOLOGY (2010)
Hot spots of retroviral integration in human CD34+ hematopoietic cells
Claudia Cattoglio et al.
BLOOD (2007)
Downstream processing of monoclonal antibodies - Application of platform approaches
Abhinav A. Shukla et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Decay rates of human mRNAs: Correlation with functional characteristics and sequence attributes
E Yang et al.
GENOME RESEARCH (2003)
Share Paper
